Immunoassay Analyzers Market Size, Share & Trends Analysis Report By Product (Chemiluminescence Immunoassays, Fluorescence Immunoassay, Radioimmunoassay), By Application (Oncology, Cardiology), By End-use, By Region And Segment Forecasts, 2025 - 2030

PUBLISHED: March 11, 2025

PAGES: 150 Pages

DELIVERY TIME: 2-10 business days

ADD TO COMPARE

SELECT AN OPTION

The global Immunoassay analyzers market size was estimated at USD 7.18 billion in 2024 and is expected to grow at a CAGR of 4.13% from 2025 to 2030. The increasing prevalence of chronic diseases, including both infectious and non-infectious conditions, is a significant driver of market growth for immunoassay analyzers. As the burden of diseases such as cancer and cardiovascular conditions continues to rise, technological advancements and the application of immunoassay analyzers are expanding rapidly. These advancements play a crucial role in early diagnosis, disease monitoring, and treatment planning. The World Health Organization (WHO) reported approximately 20 million new cancer cases in 2022, with a projected increase in diagnoses reaching 53.5 million in the coming years. This surge in chronic illnesses is fueling the demand for innovative immunoassay solutions, leading companies to develop more advanced and effective diagnostic technologies.

The outbreak of the COVID-19 pandemic further emphasized the need for rapid and accurate diagnostic tools. The emergence of the SARS-CoV-2 virus created an urgent demand for accelerated diagnostic methods that could offer both precision and affordability. While RT-PCR tests were widely used for early detection, they were often considered expensive and resource-intensive. This led to the widespread deployment of immunoassay analyzers for detecting antibodies, providing a more cost-effective and efficient alternative. Companies responded swiftly to this demand by launching advanced immunoassay solutions. For instance, Agilent Technologies, Inc. introduced the Agilent Dako SARS-CoV-2 enzyme-linked immunoassay kit, designed to detect SARS-CoV-2 antibodies in human serum or plasma. The pandemic heightened awareness about the capabilities of immunoassay analyzers, accelerating technological developments and market expansion.

The increasing prevalence of chronic diseases has driven continuous advancements in immunoassay technologies. The emergence of new infectious diseases, growing concerns over antibiotic resistance, and the rising demand for personalized medicine have spurred the need for highly sensitive, specific, and rapid immunoassay tests. Various companies are investing in innovative solutions to meet these evolving healthcare needs. Diamond Diagnostics, for example, is committed to enhancing immunoassay diagnostics by manufacturing high-quality, cost-effective consumables and accessories for immunoassay analyzers. Such innovations contribute to the expansion of the market, ensuring that healthcare providers have access to reliable and advanced diagnostic tools.

In addition to technological advancements, strategic collaborations among key industry players are significantly contributing to market growth. Companies are increasingly forming partnerships to strengthen their immunoassay capabilities, support therapeutic advancements, and facilitate clinical adoption. A notable example is the collaboration between Beckman Coulter, Inc. and Fujirebio in July 2023. This partnership aims to enhance immunoassay applications in neurodegenerative disease research, clinical trials, routine diagnostics, and reimbursement processes. By combining expertise and resources, these collaborations are driving innovation and improving the accessibility of advanced diagnostic solutions.

Global Immunoassay Analyzers Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For the purpose of this study, Grand View Research has segmented the global Immunoassay analyzers market report on the basis of product, application, end use, region:

Product Outlook (Revenue, USD Million, 2018 - 2030)
Chemiluminescence Immunoassays (CLIA)
Fluorescence Immunoassays (FIA)
Radioimmunoassay
Enzyme-Linked Immunoassay
Consumables and Accessories
Application Outlook (Revenue, USD Million, 2018 - 2030)
Therapeutic Drug Monitoring
Oncology
Cardiology
Endocrinology
Infectious Disease Testing
Autoimmune Disease
Others
End-use Outlook (Revenue, USD Million, 2018 - 2030)
Hospitals & Clinics
Diagnostic Laboratories
Research Institutes
Regional Outlook (Revenue in USD Million, 2018 - 2030)
North America
- U.S.
- Canada
- Mexico
Europe
- UK
- Germany
- France
- Italy
- Spain
- Sweden
- Denmark
- Norway
Asia Pacific
- Japan
- China
- India
- Australia
- South Korea
- Thailand
Latin America
- Brazil
- Argentina
Middle East and Africa
- Saudi Arabia
- South Africa
- UAE
- Kuwait

Product Code: GVR-1-68038-992-0

Chapter 1. Methodology and Scope

1.1. Market Segmentation & Scope
1.2. Segment Definitions
- 1.2.1. Product
- 1.2.2. Application
- 1.2.3. End Use
- 1.2.4. Regional scope
- 1.2.5. Estimates and forecasts timeline.
1.3. Research Methodology
1.4. Information Procurement
- 1.4.1. Purchased database
- 1.4.2. GVR's internal database
- 1.4.3. Secondary sources
- 1.4.4. Primary research
- 1.4.5. Details of primary research
1.5. Information or Data Analysis
- 1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
- 1.7.1. Commodity flow analysis (Model 1)
- 1.7.2. Approach 1: Commodity flow approach
- 1.7.3. Volume price analysis (Model 2)
- 1.7.4. Approach 2: Volume price analysis
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives

Chapter 2. Executive Summary

2.1. Market Outlook
2.2. Segment Outlook
- 2.2.1. Product outlook
- 2.2.2. Application outlook
- 2.2.3. End Use outlook
- 2.2.4. Regional outlook
2.3. Competitive Insights

Chapter 3. Immunoassay Analyzers Market Variables, Trends & Scope

3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.1.2. Related/ancillary market outlook.
3.2. Market Dynamics
- 3.2.1. Market driver analysis
  - 3.2.1.1. Rising Prevalence of chronic and infectious diseases
  - 3.2.1.2. Technological advancements
  - 3.2.1.3. Growing adoption of personalized products
  - 3.2.1.4. Growing investments and collaborations
- 3.2.2. Market restraint analysis
  - 3.2.2.1. High costs and operational complexity
3.3. Immunoassay Analyzers Market Analysis Tools
- 3.3.1. Industry Analysis - Porter's
- 3.3.2. PESTEL Analysis
3.4. Case Study

Chapter 4. Immunoassay Analyzers Market: Product Estimates & Trend Analysis

4.1. Products Market Share, 2024 & 2030
4.2. Segment Dashboard
4.3. Immunoassay Analyzers Market: Product Movement Analysis
4.4. Immunoassay Analyzers Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
4.5. Chemiluminescence Immunoassays (CLIA)
- 4.5.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.6. Fluorescence Immunoassays (FIA)
- 4.6.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.7. Radioimmunoassay
- 4.7.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.8. Enzyme-Linked Immunoassay
- 4.8.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.9. vConsumables and Accessories
- 4.9.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.10. Consumables and Accessories
- 4.10.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Immunoassay Analyzers Market: Application Estimates & Trend Analysis

5.1. Application Market Share, 2024 & 2030
5.2. Segment Dashboard
5.3. Global Immunoassay Analyzers Market by Application Outlook
5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
5.5. Therapeutic Drug Monitoring
- 5.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.6. Oncology
- 5.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.7. Cardiology
- 5.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.8. Endocrinology
- 5.8.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.9. Infectious Disease Testing
- 5.9.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.10. Autoimmune Disease
- 5.10.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.11. Others
- 5.11.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Immunoassay Analyzers Market: End Use Estimates & Trend Analysis

6.1. End Use Market Share, 2024 & 2030
6.2. Segment Dashboard
6.3. Global Immunoassay Analyzers Market by End Use Outlook
6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
6.5. Hospitals & Clinics
- 6.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
6.6. Diagnostic Laboratories
- 6.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
6.7. Research Institutes
- 6.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Immunoassay Analyzers Market: Regional Estimates & Trend Analysis

7.1. Regional Market Share Analysis, 2024 & 2030
7.2. Regional Market Dashboard
7.3. Global Regional Market Snapshot
7.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
7.5. North America
- 7.5.1. North America: SWOT Analysis
- 7.5.2. U.S.
  - 7.5.2.1. Key country dynamics
  - 7.5.2.2. Regulatory framework/Reimbursement
  - 7.5.2.3. Competitive scenario
  - 7.5.2.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
- 7.5.3. Canada
  - 7.5.3.1. Key country dynamics
  - 7.5.3.2. Regulatory framework/Reimbursement
  - 7.5.3.3. Competitive scenario
  - 7.5.3.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
- 7.5.4. Mexico
  - 7.5.4.1. Key country dynamics
  - 7.5.4.2. Regulatory framework/Reimbursement
  - 7.5.4.3. Competitive scenario
  - 7.5.4.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
7.6. Europe
- 7.6.1. Europe: SWOT Analysis
- 7.6.2. UK
  - 7.6.2.1. Key country dynamics
  - 7.6.2.2. Regulatory framework/Reimbursement
  - 7.6.2.3. Competitive scenario
  - 7.6.2.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
- 7.6.3. Germany
  - 7.6.3.1. Key country dynamics
  - 7.6.3.2. Regulatory framework/Reimbursement
  - 7.6.3.3. Competitive scenario
  - 7.6.3.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
- 7.6.4. France
  - 7.6.4.1. Key country dynamics
  - 7.6.4.2. Regulatory framework/Reimbursement
  - 7.6.4.3. Competitive scenario
  - 7.6.4.4. France market estimates and forecasts 2018 to 2030 (USD Million)
- 7.6.5. Italy
  - 7.6.5.1. Key country dynamics
  - 7.6.5.2. Regulatory framework/Reimbursement
  - 7.6.5.3. Competitive scenario
  - 7.6.5.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
- 7.6.6. Spain
  - 7.6.6.1. Key country dynamics
  - 7.6.6.2. Regulatory framework/Reimbursement
  - 7.6.6.3. Competitive scenario
  - 7.6.6.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
- 7.6.7. Norway
  - 7.6.7.1. Key country dynamics
  - 7.6.7.2. Regulatory framework/Reimbursement
  - 7.6.7.3. Competitive scenario
  - 7.6.7.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
- 7.6.8. Sweden
  - 7.6.8.1. Key country dynamics
  - 7.6.8.2. Regulatory framework/Reimbursement
  - 7.6.8.3. Competitive scenario
  - 7.6.8.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
- 7.6.9. Denmark
  - 7.6.9.1. Key country dynamics
  - 7.6.9.2. Regulatory framework/Reimbursement
  - 7.6.9.3. Competitive scenario
  - 7.6.9.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
7.7. Asia Pacific
- 7.7.1. Asia Pacific: SWOT Analysis
- 7.7.2. Japan
  - 7.7.2.1. Key country dynamics
  - 7.7.2.2. Regulatory framework/Reimbursement
  - 7.7.2.3. Competitive scenario
  - 7.7.2.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
- 7.7.3. China
  - 7.7.3.1. Key country dynamics
  - 7.7.3.2. Regulatory framework/Reimbursement
  - 7.7.3.3. Competitive scenario
  - 7.7.3.4. China market estimates and forecasts 2018 to 2030 (USD Million)
- 7.7.4. India
  - 7.7.4.1. Key country dynamics
  - 7.7.4.2. Regulatory framework/Reimbursement
  - 7.7.4.3. Competitive scenario
  - 7.7.4.4. India market estimates and forecasts 2018 to 2030 (USD Million)
- 7.7.5. Australia
  - 7.7.5.1. Key country dynamics
  - 7.7.5.2. Regulatory framework/Reimbursement
  - 7.7.5.3. Competitive scenario
  - 7.7.5.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
- 7.7.6. South Korea
  - 7.7.6.1. Key country dynamics
  - 7.7.6.2. Regulatory framework/Reimbursement
  - 7.7.6.3. Competitive scenario
  - 7.7.6.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
- 7.7.7. Thailand
  - 7.7.7.1. Key country dynamics
  - 7.7.7.2. Regulatory framework/Reimbursement
  - 7.7.7.3. Competitive scenario
  - 7.7.7.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
7.8. Latin America
- 7.8.1. Latin America: SWOT Analysis
- 7.8.2. Brazil
  - 7.8.2.1. Key country dynamics
  - 7.8.2.2. Regulatory framework/Reimbursement
  - 7.8.2.3. Competitive scenario
  - 7.8.2.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
- 7.8.3. Argentina
  - 7.8.3.1. Key country dynamics
  - 7.8.3.2. Regulatory framework/Reimbursement
  - 7.8.3.3. Competitive scenario
  - 7.8.3.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
7.9. MEA
- 7.9.1. MEA: SWOT Analysis
- 7.9.2. South Africa
  - 7.9.2.1. Key country dynamics
  - 7.9.2.2. Regulatory framework/Reimbursement
  - 7.9.2.3. Competitive scenario
  - 7.9.2.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
- 7.9.3. Saudi Arabia
  - 7.9.3.1. Key country dynamics
  - 7.9.3.2. Regulatory framework/Reimbursement
  - 7.9.3.3. Competitive scenario
  - 7.9.3.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
- 7.9.4. UAE
  - 7.9.4.1. Key country dynamics
  - 7.9.4.2. Regulatory framework/Reimbursement
  - 7.9.4.3. Competitive scenario
  - 7.9.4.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
- 7.9.5. Kuwait
  - 7.9.5.1. Key country dynamics
  - 7.9.5.2. Regulatory framework
  - 7.9.5.3. Competitive scenario
  - 7.9.5.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

8.1. Recent Developments & Impact Analysis, By Key Market Participants
8.2. Company/Competition Categorization
8.3. Vendor Landscape
- 8.3.1. List of key distributors and channel partners
- 8.3.2. Key customers
- 8.3.3. Key company market share analysis, 2024
- 8.3.4. Siemens Healthineers AG
  - 8.3.4.1. Company overview
  - 8.3.4.2. Financial performance
  - 8.3.4.3. Services benchmarking
  - 8.3.4.4. Strategic initiatives
- 8.3.5. BIOMERIEUX
  - 8.3.5.1. Company overview
  - 8.3.5.2. Financial performance
  - 8.3.5.3. Services benchmarking
  - 8.3.5.4. Strategic initiatives
- 8.3.6. FAbbott
  - 8.3.6.1. Company overview
  - 8.3.6.2. Financial performance
  - 8.3.6.3. Services benchmarking
  - 8.3.6.4. Strategic initiatives
- 8.3.7. QuidelOrtho Corporation
  - 8.3.7.1. Company overview
  - 8.3.7.2. Financial performance
  - 8.3.7.3. Services benchmarking
  - 8.3.7.4. Strategic initiatives
- 8.3.8. Sysmex Corporation
  - 8.3.8.1. Company overview
  - 8.3.8.2. Financial performance
  - 8.3.8.3. Services benchmarking
  - 8.3.8.4. Strategic initiatives
- 8.3.9. BD
  - 8.3.9.1. Company overview
  - 8.3.9.2. Financial performance
  - 8.3.9.3. Services benchmarking
  - 8.3.9.4. Strategic initiatives
- 8.3.10. Thermo Fisher Scientific Inc.
  - 8.3.10.1. Company overview
  - 8.3.10.2. Financial performance
  - 8.3.10.3. Services benchmarking
  - 8.3.10.4. Strategic initiatives
- 8.3.11. F. Hoffmann-La Roche Ltd
  - 8.3.11.1. Company overview
  - 8.3.11.2. Financial performance
  - 8.3.11.3. Services benchmarking
  - 8.3.11.4. Strategic initiatives
- 8.3.12. Beckman Coulter, Inc.
  - 8.3.12.1. Company overview
  - 8.3.12.2. Financial performance
  - 8.3.12.3. Services benchmarking
  - 8.3.12.4. Strategic initiatives
- 8.3.13. DiaSorin S.p.A.
  - 8.3.13.1. Company overview
  - 8.3.13.2. Financial performance
  - 8.3.13.3. Services benchmarking
  - 8.3.13.4. Strategic initiatives

Product Code: GVR-1-68038-992-0

List of Tables

Table 1 List of abbreviations
Table 2 North America immunoassay analyzers market, by region, 2018 - 2030 (USD Million)
Table 3 North America immunoassay analyzers market, by product, 2018 - 2030 (USD Million)
Table 4 North America immunoassay analyzers market, by application, 2018 - 2030 (USD Million)
Table 5 North America immunoassay analyzers market, by end use, 2018 - 2030 (USD Million)
Table 6 U.S. immunoassay analyzers market, by product, 2018 - 2030 (USD Million)
Table 7 U.S. immunoassay analyzers market, by application, 2018 - 2030 (USD Million)
Table 8 U.S. immunoassay analyzers market, by end use, 2018 - 2030 (USD Million)
Table 9 Canada immunoassay analyzers market, by product, 2018 - 2030 (USD Million)
Table 10 Canada immunoassay analyzers market, by application, 2018 - 2030 (USD Million)
Table 11 Canada immunoassay analyzers market, by end use, 2018 - 2030 (USD Million)
Table 12 Mexico immunoassay analyzers market, by product, 2018 - 2030 (USD Million)
Table 13 Mexico immunoassay analyzers market, by application, 2018 - 2030 (USD Million)
Table 14 Mexico immunoassay analyzers market, by end use, 2018 - 2030 (USD Million)
Table 15 Europe immunoassay analyzers market, by region, 2018 - 2030 (USD Million)
Table 16 Europe immunoassay analyzers market, by product, 2018 - 2030 (USD Million)
Table 17 Europe immunoassay analyzers market, by application, 2018 - 2030 (USD Million)
Table 18 Europe immunoassay analyzers market, by end use, 2018 - 2030 (USD Million)
Table 19 Germany immunoassay analyzers market, by product, 2018 - 2030 (USD Million)
Table 20 Germany immunoassay analyzers market, by application, 2018 - 2030 (USD Million)
Table 21 Germany immunoassay analyzers market, by end use, 2018 - 2030 (USD Million)
Table 22 UK immunoassay analyzers market, by product, 2018 - 2030 (USD Million)
Table 23 UK immunoassay analyzers market, by application, 2018 - 2030 (USD Million)
Table 24 UK immunoassay analyzers market, by end use, 2018 - 2030 (USD Million)
Table 25 France immunoassay analyzers market, by product, 2018 - 2030 (USD Million)
Table 26 France immunoassay analyzers market, by application, 2018 - 2030 (USD Million)
Table 27 France immunoassay analyzers market, by end use, 2018 - 2030 (USD Million)
Table 28 Italy immunoassay analyzers market, by product, 2018 - 2030 (USD Million)
Table 29 Italy immunoassay analyzers market, by application, 2018 - 2030 (USD Million)
Table 30 Italy immunoassay analyzers market, by end use, 2018 - 2030 (USD Million)
Table 31 Spain immunoassay analyzers market, by product, 2018 - 2030 (USD Million)
Table 32 Spain immunoassay analyzers market, by application, 2018 - 2030 (USD Million)
Table 33 Spain immunoassay analyzers market, by end use, 2018 - 2030 (USD Million)
Table 34 Denmark immunoassay analyzers market, by product, 2018 - 2030 (USD Million)
Table 35 Denmark immunoassay analyzers market, by application, 2018 - 2030 (USD Million)
Table 36 Denmark immunoassay analyzers market, by end use, 2018 - 2030 (USD Million)
Table 37 Sweden immunoassay analyzers market, by product, 2018 - 2030 (USD Million)
Table 38 Sweden immunoassay analyzers market, by application, 2018 - 2030 (USD Million)
Table 39 Sweden immunoassay analyzers market, by end use, 2018 - 2030 (USD Million)
Table 40 Norway immunoassay analyzers market, by product, 2018 - 2030 (USD Million)
Table 41 Norway immunoassay analyzers market, by application, 2018 - 2030 (USD Million)
Table 42 Norway immunoassay analyzers market, by end use, 2018 - 2030 (USD Million)
Table 43 Asia Pacific immunoassay analyzers market, by region, 2018 - 2030 (USD Million)
Table 44 Asia Pacific immunoassay analyzers market, by product, 2018 - 2030 (USD Million)
Table 45 Asia Pacific immunoassay analyzers market, by application, 2018 - 2030 (USD Million)
Table 46 Asia Pacific immunoassay analyzers market, by end use, 2018 - 2030 (USD Million)
Table 47 China immunoassay analyzers market, by product, 2018 - 2030 (USD Million)
Table 48 China immunoassay analyzers market, by application, 2018 - 2030 (USD Million)
Table 49 China immunoassay analyzers market, by end use, 2018 - 2030 (USD Million)
Table 50 Japan immunoassay analyzers market, by product, 2018 - 2030 (USD Million)
Table 51 Japan immunoassay analyzers market, by application, 2018 - 2030 (USD Million)
Table 52 Japan immunoassay analyzers market, by end use, 2018 - 2030 (USD Million)
Table 53 India immunoassay analyzers market, by product, 2018 - 2030 (USD Million)
Table 54 India immunoassay analyzers market, by application, 2018 - 2030 (USD Million)
Table 55 India immunoassay analyzers market, by end use, 2018 - 2030 (USD Million)
Table 56 South Korea immunoassay analyzers market, by product, 2018 - 2030 (USD Million)
Table 57 South Korea immunoassay analyzers market, by application, 2018 - 2030 (USD Million)
Table 58 South Korea immunoassay analyzers market, by end use, 2018 - 2030 (USD Million)
Table 59 Australia immunoassay analyzers market, by product, 2018 - 2030 (USD Million)
Table 60 Australia immunoassay analyzers market, by application, 2018 - 2030 (USD Million)
Table 61 Australia immunoassay analyzers market, by end use, 2018 - 2030 (USD Million)
Table 62 Thailand immunoassay analyzers market, by product, 2018 - 2030 (USD Million)
Table 63 Thailand immunoassay analyzers market, by application, 2018 - 2030 (USD Million)
Table 64 Thailand immunoassay analyzers market, by end use, 2018 - 2030 (USD Million)
Table 65 Latin America immunoassay analyzers market, by product, 2018 - 2030 (USD Million)
Table 66 Latin America immunoassay analyzers market, by application, 2018 - 2030 (USD Million)
Table 67 Latin America immunoassay analyzers market, by end use, 2018 - 2030 (USD Million)
Table 68 Brazil immunoassay analyzers market, by product, 2018 - 2030 (USD Million)
Table 69 Brazil immunoassay analyzers market, by application, 2018 - 2030 (USD Million)
Table 70 Brazil immunoassay analyzers market, by end use, 2018 - 2030 (USD Million)
Table 71 Argentina immunoassay analyzers market, by product, 2018 - 2030 (USD Million)
Table 72 Argentina immunoassay analyzers market, by application, 2018 - 2030 (USD Million)
Table 73 Argentina immunoassay analyzers market, by end use, 2018 - 2030 (USD Million)
Table 74 MEA immunoassay analyzers market, by region, 2018 - 2030 (USD Million)
Table 75 MEA immunoassay analyzers market, by product, 2018 - 2030 (USD Million)
Table 76 MEA immunoassay analyzers market, by application, 2018 - 2030 (USD Million)
Table 77 MEA immunoassay analyzers market, by end use, 2018 - 2030 (USD Million)
Table 78 South Africa immunoassay analyzers market, by product, 2018 - 2030 (USD Million)
Table 79 South Africa immunoassay analyzers market, by application, 2018 - 2030 (USD Million)
Table 80 South Africa immunoassay analyzers market, by end use, 2018 - 2030 (USD Million)
Table 81 Saudi Arabia immunoassay analyzers market, by product, 2018 - 2030 (USD Million)
Table 82 Saudi Arabia immunoassay analyzers market, by application, 2018 - 2030 (USD Million)
Table 83 Saudi Arabia immunoassay analyzers market, by end use, 2018 - 2030 (USD Million)
Table 84 UAE immunoassay analyzers market, by product, 2018 - 2030 (USD Million)
Table 85 UAE immunoassay analyzers market, by application, 2018 - 2030 (USD Million)
Table 86 UAE immunoassay analyzers market, by end use, 2018 - 2030 (USD Million)
Table 87 Kuwait immunoassay analyzers market, by product, 2018 - 2030 (USD Million)
Table 88 Kuwait immunoassay analyzers market, by application, 2018 - 2030 (USD Million)

List of Figures

Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Primary interviews in North America
Fig. 5 Primary interviews in Europe
Fig. 6 Primary interviews in APAC
Fig. 7 Primary interviews in Latin America
Fig. 8 Primary interviews in MEA
Fig. 9 Market research approaches
Fig. 10 Value-chain-based sizing & forecasting
Fig. 11 QFD modeling for market share assessment
Fig. 12 Market formulation & validation
Fig. 13 Immunoassay analyzers market: market outlook
Fig. 14 Immunoassay analyzers competitive insights
Fig. 15 Parent market outlook
Fig. 16 Related/ancillary market outlook
Fig. 17 Penetration and growth prospect mapping
Fig. 18 Industry value chain analysis
Fig. 19 Immunoassay analyzers market driver impact
Fig. 20 Immunoassay analyzers market restraint impact
Fig. 21 Immunoassay analyzers market strategic initiatives analysis
Fig. 22 Immunoassay analyzers market: Product movement analysis
Fig. 23 Immunoassay analyzers market: Product outlook and key takeaways
Fig. 24 Chemiluminescence Immunoassays (CLIA) market estimates and forecast, 2018 - 2030
Fig. 25 Fluorescence Immunoassays (FIA) market estimates and forecast, 2018 - 2030
Fig. 26 Radioimmunoassay market estimates and forecast, 2018 - 2030
Fig. 27 Enzyme-Linked Immunoassay market estimates and forecast, 2018 - 2030
Fig. 28 Consumables and Accessories market estimates and forecast, 2018 - 2030
Fig. 29 Immunoassay analyzers Market: Application movement analysis
Fig. 30 Immunoassay analyzers market: Application outlook and key takeaways
Fig. 31 Therapeutic drug monitoring market estimates and forecasts, 2018 - 2030
Fig. 32 Oncology market estimates and forecasts, 2018 - 2030
Fig. 33 Cardiology market estimates and forecasts, 2018 - 2030
Fig. 34 Endocrinology market estimates and forecasts, 2018 - 2030
Fig. 35 Infectious disease testing market estimates and forecasts, 2018 - 2030
Fig. 36 Autoimmune disease market estimates and forecasts, 2018 - 2030
Fig. 37 Others market estimates and forecasts, 2018 - 2030
Fig. 38 Immunoassay analyzers market: End use movement analysis
Fig. 39 Immunoassay analyzers market: End- use outlook and key takeaways
Fig. 40 Hospitals & clinics market estimates and forecasts, 2018 - 2030
Fig. 41 Diagnostic laboratories market estimates and forecasts, 2018 - 2030
Fig. 42 Research Institutes market estimates and forecasts, 2018 - 2030
Fig. 43 Global immunoassay analyzers market: Regional movement analysis
Fig. 44 Global immunoassay analyzers market: Regional outlook and key takeaways
Fig. 45 Global immunoassay analyzers market share and leading players
Fig. 46 North America market share and leading players
Fig. 47 Europe market share and leading players
Fig. 48 Asia Pacific market share and leading players
Fig. 49 Latin America market share and leading players
Fig. 50 Middle East & Africa market share and leading players
Fig. 51 North America: SWOT
Fig. 52 Europe SWOT
Fig. 53 Asia Pacific SWOT
Fig. 54 Latin America SWOT
Fig. 55 MEA SWOT
Fig. 56 North America, by country
Fig. 57 North America
Fig. 58 North America market estimates and forecasts, 2018 - 2030
Fig. 59 U.S.
Fig. 60 U.S. market estimates and forecasts, 2018 - 2030
Fig. 61 Canada
Fig. 62 Canada market estimates and forecasts, 2018 - 2030
Fig. 63 Mexico
Fig. 64 Mexico market estimates and forecasts, 2018 - 2030
Fig. 65 Europe
Fig. 66 Europe market estimates and forecasts, 2018 - 2030
Fig. 67 UK
Fig. 68 UK market estimates and forecasts, 2018 - 2030
Fig. 69 Germany
Fig. 70 Germany market estimates and forecasts, 2018 - 2030
Fig. 71 France
Fig. 72 France market estimates and forecasts, 2018 - 2030
Fig. 73 Italy
Fig. 74 Italy market estimates and forecasts, 2018 - 2030
Fig. 75 Spain
Fig. 76 Spain market estimates and forecasts, 2018 - 2030
Fig. 77 Denmark
Fig. 78 Denmark market estimates and forecasts, 2018 - 2030
Fig. 79 Sweden
Fig. 80 Sweden market estimates and forecasts, 2018 - 2030
Fig. 81 Norway
Fig. 82 Norway market estimates and forecasts, 2018 - 2030
Fig. 83 Asia Pacific
Fig. 84 Asia Pacific market estimates and forecasts, 2018 - 2030
Fig. 85 China
Fig. 86 China market estimates and forecasts, 2018 - 2030
Fig. 87 Japan
Fig. 88 Japan market estimates and forecasts, 2018 - 2030
Fig. 89 India
Fig. 90 India market estimates and forecasts, 2018 - 2030
Fig. 91 Thailand
Fig. 92 Thailand market estimates and forecasts, 2018 - 2030
Fig. 93 South Korea
Fig. 94 South Korea market estimates and forecasts, 2018 - 2030
Fig. 95 Australia
Fig. 96 Australia market estimates and forecasts, 2018 - 2030
Fig. 97 Latin America
Fig. 98 Latin America market estimates and forecasts, 2018 - 2030
Fig. 99 Brazil
Fig. 100 Brazil market estimates and forecasts, 2018 - 2030
Fig. 101 Argentina
Fig. 102 Argentina market estimates and forecasts, 2018 - 2030
Fig. 103 Middle East and Africa
Fig. 104 Middle East and Africa market estimates and forecasts, 2018 - 2030
Fig. 105 South Africa
Fig. 106 South Africa market estimates and forecasts, 2018 - 2030
Fig. 107 Saudi Arabia
Fig. 108 Saudi Arabia market estimates and forecasts, 2018 - 2030
Fig. 109 UAE
Fig. 110 UAE market estimates and forecasts, 2018 - 2030
Fig. 111 Kuwait
Fig. 112 Kuwait market estimates and forecasts, 2018 - 2030
Fig. 113 Market share of key market players- Immunoassay analyzers market